Sodium Zirconium Cyclosilicate in Chronic Kidney Disease, Hyperkalemia, and Metabolic Acidosis: NEUTRALIZE Randomized Study.

Published in: Kidney360 (2024)

SZC effectively lowered sK+ and maintained normokalemia, with nominally significant increases in sHCO3- observed for SZC versus placebo.

Keyphrases